| AMP | Adenosine Mono-Phosphate |
|---|---|
| amp. | ample |
| AK amp | above-knee amputation |
| AMP | accelerated mental processes; acid mucopolysaccharide; adenosine monophosphate; amphetamine; ampicil... |
| amp | ampere; amplification; ampule; amputation, amputee |
| DBcyclic AMP | Dibutyryl cyclic AMP |
|---|---|
| BOAI | Balloon occluded arterial infusion |
| B.H.I. | Brain Heart Infusion |
| BHI | Brain Heart Infusion Broth |
| BHIB | Brain Heart Infusion Broth |
| brain-heart infusion agar | A medium used for the isolation of fastidious microorganisms, especially fungi. (05 Mar 2000) |
|---|---|
| constant infusion pump | An electrically driven device for delivery from a reservoir of a constant, often very small, volume of solution over a prolonged period of time. (05 Mar 2000) |
| home infusion therapy | Use of any infusion therapy on an ambulatory, outpatient, or other non-institutionalised basis. (12 Dec 1998) |
| infusion | The therapeutic introduction of a fluid other than blood, as saline solution, solution, into a vein. (18 Nov 1997) |
| infusion-aspiration drainage | A type of drainage in which antibiotics are continuously infused into a cavity at the same time fluid is being drained (aspirated) from the cavity. Synonym: drip-suck irrigation. (05 Mar 2000) |
| infusion graft | Transplantation by injection of a suspension of cells. (05 Mar 2000) |
| infusion pumps | Fluid propulsion systems driven mechanically, electrically, or osmotically that are used to inject (or infuse) over time agents into a patient or experimental animal; used routinely in hospitals to maintain a patent intravenous line, to administer antineoplastic agent and other drugs in thromboembolism, heart disease, diabetes mellitus (insulin infusion systems is also available), and other disorders. (12 Dec 1998) |
| infusion pumps, implantable | Implanted fluid propulsion systems with self-contained power source for providing long-term controlled-rate delivery of drugs such as chemotherapeutic agents or analgesics. Delivery rate may be externally controlled or osmotically or peristaltically controlled with the aid of transcutaneous monitoring. (12 Dec 1998) |
| insulin infusion systems | Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor. (12 Dec 1998) |
| intravenous infusion | <pharmacology> The giving of antibiotics, blood products, anti-cancer drugs or nutrients into a patients vein over a prolonged period of time. (30 Mar 1998) |
| AMP | <abbreviation> Adenosine monophosphate; specifically, the 5'-monophosphate unless modified by a numerical prefix. See: adenylic acid. (05 Mar 2000) |
| AMP-activated protein kinase kinase | <enzyme> An endogenous kinase kinase; reactivates the inactive form of AMP-activated protein kinase (AMP-pk); phosphorylates the 63-kD subunit of AMP-pk Registry number: EC 2.7.1.- Synonym: AMP-pk reactivator, hmg CoA reductase kinase kinase (26 Jun 1999) |
| AMP deaminase | <enzyme> An enzyme that catalyses the deamination of AMP to imp. Chemical name: AMP aminohydrolase Registry number: EC 3.5.4.6 (12 Dec 1998) |
| receptors, cyclic AMP | Cell surface proteins that bind cyclic AMP with high affinity and trigger intracellular changes which influence the behaviour of cells. The best characterised cyclic AMP receptors are those of the slime mold dictyostelium discoideum. The transcription regulator cyclic AMP receptor protein of prokaryotes is not included nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins which are the regulatory subunits of cyclic AMP-dependent protein kinases. (12 Dec 1998) |
| polyphosphate AMP phosphotransferase | <enzyme> From acinetobacter; catalyses (polyphosphate)n and AMP to (polyphosphate)n-1 and ADP Registry number: EC 2.7.4.- Synonym: pamp phosphotransferase (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
헬포빈인퓨전주사액 - 새창
|
대원제약 |
A12802741 | L-Ornithine-L-Aspartate | 전문의약품 | 급여 |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|